NFO period: 20^th June – 04^th July, 2019

Highlights of the NFO:

• Scheme type – An open ended equity scheme investing in Pharma and Healthcare Services Sector


• Investment objective – The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.


• Product suitability – The product is suitable for investors who are seeking long term capital growth by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.


• Minimum Application Amount – First investment is Rs. 1,000/- and in multiples of Rs. 1/- thereafter


• Plan/ Options available – Regular Plan and Direct Plan having Growth Option and Dividend Option (Payout & Reinvestment Facility).


• Fund Manager – Mr. Dhaval Shah


• Benchmark – S&P BSE Healthcare TRI